PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease

Cell and Bioscience

Volumn 2, Issue 1, 2012, Pages

  Qu, Zhaoxia ^a,b   Fu, Jing ^a,b   Ma, Huihui ^a,c   Zhou, Jingjiao ^a,b   Jin, Meihua ^a,b   Mapara, Markus Y ^a,c   Grusby, Michael J ^d   Xiao, Gutian ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b Department of Microbiology and Molecular Genetics ^*  (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

EID: 84872300469     PISSN: None     EISSN: 20453701     Source Type: Journal    
DOI: 10.1186/2045-3701-2-23     Document Type: Article

References (29)

1. O'Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010, 327:1098-1102. 10.1126/science.1178334, 2997673, 20185720.
2. Jäger A, Kuchroo VK. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 2010, 72:173-184. 10.1111/j.1365-3083.2010.02432.x, 3129000, 20696013.
3. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 2010, 162:1-11. 10.1111/j.1365-2249.2010.04143.x, 2990924, 20682002.
4. Toh ML, Miossec P. The role of T cells in rheumatoid arthritis: new subsets and new targets. Curr Opin Rheumatol 2007, 19:284-288. 10.1097/BOR.0b013e32805e87e0, 17414957.
5. Xiao G, Rabson A, Young W, Qing G, Qu Z. Alternative pathways of NF-κB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev 2006, 17:281-293. 10.1016/j.cytogfr.2006.04.005, 16793322.
6. Brown KD, Claudio E, Siebenlist U. The roles of the classical and alternative nuclear factor-κB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther 2008, 10:212. 10.1186/ar2457, 2575629, 18771589.
7. Santos CI, Costa-Pereira AP. Signal transducers and activators of transcription-from cytokine signaling to cancer biology. Biochim Biophys Acta 2011, 1816:38-49.
8. Xiao G, Fu J. NF-κB and cancer: a paradigm of Yin-Yang. Am J Cancer Res 2011, 1:192-221. 3180046, 21969033.
9. Tanaka T, Soriano MA, Grusby MJ. SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling. Immunity 2005, 22:729-736. 10.1016/j.immuni.2005.04.008, 15963787.
10. Tanaka T, Grusby MJ, Kaisho T. PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 2007, 8:584-591. 10.1038/ni1464, 17468759.
11. Qu Z, Fu J, Yan P, Hu J, Cheng S, Xiao G. Epigenetic repression of PDLIM2: implications for the biology and treatment of breast cancer. J Biol Chem 2010, 285:11786-11792. 10.1074/jbc.M109.086561, 2852914, 20185823.
12. Qu Z, Yan P, Fu J, Jiang J, Grusby MJ, Smithgall TE, Xiao G. DNA methylation-dependent repression of PDLIM2 in colon cancer and its role as a potential therapeutic target. Cancer Res 2010, 70:1766-1772. 10.1158/0008-5472.CAN-09-3263, 3003295, 20145149.
13. Yan P, Fu J, Qu Z, Li S, Tanaka T, Grusby MJ, Xiao G. PDLIM2 suppresses HTLV-I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation. Blood 2009, 113:4370-4380. 10.1182/blood-2008-10-185660, 2676091, 19131544.
14. Yan P, Qu Z, Li S, Ishikawa C, Mori N, Xiao G. HTLV-I-mediated repression of PDLIM2 involves DNA methylation but independent of the viral oncoprotein Tax. Neoplasia 2009, 11:1036-1041. 2745669, 19794962.
15. Fu J, Yan P, Li S, Qu Z, Xiao G. Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis. Onocogene 2010, 29:6499-4507.
16. Morel L. Mouse models of human autoimmune diseases: essential tools that require the proper controls. PLoS Biol 2004, 2:E241. 10.1371/journal.pbio.0020241, 509303, 15314657.
17. Lyons JA, Ramsbottom MJ, Mikesell RJ, Cross AH. B cells limit epitope spreading and reduce severity of EAE induced with PLP peptide in BALB/c mice. J Autoimmun 2008, 31:149-155. 10.1016/j.jaut.2008.04.025, 2580779, 18539432.
18. Nishikomori R, Usui T, Wu CY, Morinobu A, O'Shea JJ, Strober W. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J Immunol 2002, 169:4388-4398.
19. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, O'Malley JT, Kapur R, Levy DE, Kansas GS, Kaplan MH. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007, 178:4901-4907.
20. Ruan Q, Kameswaran V, Zhang Y, Zheng S, Sun J, Wang J, DeVirgiliis J, Liou HC, Beg AA, Chen YH. The Th17 immune response is controlled by the Rel-RORγ-RORγ T transcriptional axis. J Exp Med 2011, 208:2321-2333. 10.1084/jem.20110462, 3201209, 22006976.
21. Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, Hipkiss EL, Getnet D, Goldberg MV, Maris CH, Housseau F, Yu H, Pardoll DM, Drake CG. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 2007, 179:4313-4317.
22. Tanaka T, Yamamoto Y, Muromoto R, Ikeda O, Sekine Y, Grusby MJ, Kaisho T, Matsuda T. PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3. Sci Signal 2011, 4:ra85. 10.1126/scisignal.2001637, 22155789.
23. Qu Z, Sun D, Young W. Lithium promotes neural precursor cell proliferation: evidence for the involvement of the non-canonical GSK-3β-NF-AT signaling. Cell Biosci 2011, 1:18. 10.1186/2045-3701-1-18, 3125208, 21711903.
24. Fu J, Qu Z, Yan P, Ishikawa C, Ageilan RI, Rabson AB, Xiao G. The tumor suppressor gene WWOX links the canonical and noncanonical NF-κB pathways in HTLV-I Tax-mediated tumorigenesis. Blood 2011, 117:1652-1661. 10.1182/blood-2010-08-303073, 3318777, 21115974.
25. Qing G, Qu Z, Xiao G. Endoproteolytic processing of C-terminally truncated NF-κB2 precursors at κB-containing promoters. Proc Natl Acad Sci U S A 2007, 104:5324-5329. 10.1073/pnas.0609914104, 1838492, 17363471.
26. Qing G, Qu Z, Xiao G. Regulation of NF-κB2 p100 processing by its cis-activating domain. J Biol Chem 2005, 280:18-27.
27. Qing G, Yan P, Xiao G. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IκB kinase (IKK). Cell Res 2006, 16:895-901. 10.1038/sj.cr.7310109, 17088896.
28. Qu Z, Qing G, Rabson R, Xiao G. Tax deregulation of NF-κB2 p100 processing involves both β-TrCP-dependent and independent mechanisms. J Biol Chem 2004, 279:44563-44572. 10.1074/jbc.M403689200, 15310758.
29. Qing G, Qu Z, Xiao G. Stabilization of basally translated NF-κB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-κB2 p100. J Biol Chem 2005, 280:40578-40582. 10.1074/jbc.M508776200, 16223731.